Skip to content

Comparative Analgesic Effects of Paracetamol/Codeine and Ibuprofen on Pain After Third Molar Surgery

Comparative Analgesic Effects of Preoperative Administration of Paracetamol (Acetominophen) 500 mg Plus Codeine 30 mg and Ibuprofen 400 mg on Pain After Third Molar Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04730297
Enrollment
120
Registered
2021-01-29
Start date
2018-01-01
Completion date
2020-10-14
Last updated
2021-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Control Pain After Third Molar Surgery

Keywords

postsurgical dental pain

Brief summary

To compare analgesic effects of preoperative administration of paracetamol 500 milligram plus codeine 30 milligram in single-tablet and effervescent formulation to ibuprofen 400 milligram, and placebo in the management of moderate to severe postoperative pain after mandibular third molar surgery.

Detailed description

Materials and methods: One hundred twenty healthy outpatients aged 15 to 29 years undergoing surgical removal of one bony impacted mandibular third molar were enrolled in this, single-center, prospective, randomized, triple-blind parallel-group, placebo-controlled, clinical trial. Study participants were randomly assigned to three treatment arms. According to the concealed allocation, each patient 30 minutes before surgery received paracetamol 500 mg plus codeine 30 mg (group A), ibuprofen 400 mg (group B) or placebo (group C). Rescue therapy allowed in the postoperative period was paracetamol 500 mg plus codeine 30 mg in groups A and C and ibuprofen 400 mg in group B. Patients recorded on Numerical Rating Scale-11 (NRS-11) the pain intensity, total number of postoperative-supplement medications and time of the first intake, until 12-hours after surgery and over extra two days

Interventions

DRUGibuprofen 400 mg preoperative administration

each patient 30 minutes before surgery received ibuprofen 400 mg

DRUGparacetamol 500 mg plus codeine 30 mg preoperative administration

each patient 30 minutes before surgery received paracetamol 500 mg plus codeine 30 mg

DRUGPlacebo oral tablet preoperative administration

each patient 30 minutes before surgery received placebo

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Intervention model description

a single-center, 2-stage, prospective, randomized, triple-blind parallel-group, placebo-controlled, clinical trial

Eligibility

Sex/Gender
ALL
Age
15 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy status (ASA class I); * nonsmoker; * not pregnant or breastfeeding; * no medication consumption in the past 21 days; * good oral hygiene; * bony impaction of one mandibular third molars; * the presence of the first and second molars; * compliance to cooperate with the research protocol.

Exclusion criteria

* chronic systemic disease; * medications with potential interaction to paracetamol-codeine or ibuprofen; * a history of intolerance or hypersensitivity to the study drugs; * any pre-existing pain and acute inflammatory or infectious conditions; - inability to understand or perform the study procedure.

Design outcomes

Primary

MeasureTime frameDescription
Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11)All study participants were asked to record the pain intensity score at 1:00 pm during the operative day]In stage 1, the objective was to misure the efficacy on pain and tolerability of a single dose of paracetamol plus codeine, ibuprofen, or placebo in the operative day. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 (no pain) to 10 (maximum pain)

Secondary

MeasureTime frameDescription
Number of patients requiring rescue therapyuntil 12-hours after surgery and over extra two daysoutcomes involved the number of patients requiring rescue therapy
first postoperative use of analgesicsuntil 12-hours after surgerytime of the first intake
total postoperative use of analgesicsuntil 12-hours after surgery and over extra two daystotal amount of additional medication

Other

MeasureTime frameDescription
Compare the efficacy of the same drugsup to 48 hours after stage 1Patients recorded on Numerical Rating Scale-11 (NRS-11) the pain intensity

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026